This study assessed the predictive accuracy of deep learning analysis by utilizing multimodal medical data to identify clinically significant cancer in patients with a low–intermediate PSA level, specifically below 20 ng/mL, before undergoing prostate biopsy. The gene discussed is KLK3; the disease is cancer.